Vaxxas

Developer of a needle-free patch technology for vaccine delivery applications

placeBrisbane, Queensland, Australia calendar_todayFounded 2010 groups113 employees language vaxxas.com

Innovation

20 patent families (13 granted) — focus: Human necessities, Operations & transport, Physics & computing, Chemistry & metallurgy; filing pace steady. Cited 6,733 times.

YearFilings
20142
20161
20174
20189
20196
20206
20219
20227
20237
20247
202511
20265

Social engagement

Social engagement: 12.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include One Ventures, UniQuest, SPRIM Global Investments.

Investor typeCountShare
Venture capital857%
Angel & family office17%
Accelerator & incubator17%
Other / undisclosed429%

Recent activity

11 Jun 2026
Event
2026 Communicable Diseases & Immunisation Conference
14 May 2026
Event
AusMedtech 2026
30 Apr 2026
Event
Queensland Biotech on the World Stage
Coming soon